Jay Rasmussen

Dr. Jay Rasmussen is a Researcher at the Queensland Brain Institute, University of Queensland, Australia, specializing in molecular mechanisms of neurodegenerative disorders. His work bridges neuropathology and genomic research, focusing on Alzheimer's disease heterogeneity, prion pathologies, and the role of somatic genomic variation in brain aging, with recent emphasis on retrotransposon activity in neural development and degeneration.

His academic foundation includes a BSc and MSc in Neurosciences from the University of Alberta, Canada, followed by a PhD at the University of Tübingen, Germany (2014) under Professor Mathias Jucker at the Hertie Institute and German Center for Neurodegenerative Diseases (DZNE). Since 2018, he has been a core member of Professor Geoffrey Faulkner's laboratory at the Queensland Brain Institute.

Dr. Rasmussen's research explores neurodegenerative disease heterogeneity through multiple lenses: amyloid-beta polymorphism in Alzheimer's subtypes, prion-like propagation mechanisms, and somatic retrotransposition in neural tissues. His seminal work revealed distinct conformational strains of amyloid plaques that define Alzheimer's etiological variants, while current research demonstrates how LINE-1 retrotransposons influence interneuron development and contribute to age-related brain dysfunction. This integrative approach combines advanced neuropathological analysis with cutting-edge genomic techniques to unravel individual differences in disease susceptibility.

Analysis of his 15 most recent publications (2014-2024) shows an evolution from classical protein aggregation studies toward genomic instability in aging brains. Early work characterized prion and amyloid seeding dynamics, while his current research pioneers retrotransposon biology in neural contexts, revealing conserved mechanisms from mouse to primate models. This trajectory highlights a strategic shift toward understanding how somatic genomic mosaicism contributes to neural diversity and vulnerability in neurodegeneration.

No scientific awards or student mentorship activities were documented in available sources. His collaborative research operates within the Faulkner Laboratory at QBI, which employs multi-omics approaches and advanced imaging to investigate somatic mosaicism in age-related brain disorders through projects involving international consortia and cross-institutional partnerships.